Navigation Links
Intellectual Property Insurance for Medical-related Products and Services
Date:1/15/2014

LOUISVILLE, Ky., Jan. 15, 2014 /PRNewswire/ -- Manufacturers, suppliers and distributors of innovative medical-related products and technologies must be able to protect their most important business assets, intellectual property (IP).

(Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO )

Because of the highly-competitive nature of the Medical Device Industry, it steadfastly remains one of the most litigious industry sectors of cases involving IP infringement. This litigious nature can easily be accredited to fast, ever-changing technology. Whether it's defending their products against predatory business practices of others, maintaining their place in the market, or enforcing their IP rights to prevent others from copying their ideas, making it their own and taking precious market share away, IP litigation is expensive and time-consuming.

IP insurance enables the policy holder to fund the litigation to enforce IP rights and/or defend against charges of IP infringement, successfully. This insurance ensures the policy holder can get through an IP lawsuit on the merits of the case, not on who has the deeper pockets to fund a lawsuit. Given its track record of success, only IPISC has been able to offer the market a full scope of IP-specific coverage including Defense, Abatement, Multi-Peril and Unauthorized Disclosure policies on a worldwide basis. IPISC has helped ensure that the funds and the litigation support have been available for the policy holder to get through the litigation process.

IPISC's president, Robert Fletcher, reminds, "It is important for this industry in particular to understand that IP exposure can be a significant risk, yet many are not proactively advising or being advised about the availability of IP insurance. Assessing IP risk and ensuring that the right insurance protection is in place for this potentially devastating and costly exposure is essential to a company's overall financial survival. As a matter of fact, we are winding up a case right now where the Insured would be out of business if they had not had the IP policy."

IP insurance is quickly becoming the most logical and economical choice that the Medical industry can make to ensure that the means are available to fund the high cost and consequences of IP litigation. For further information, please contact Janet Zahnd, Sales/Marketing Manager, at jzahnd@patentinsurance.com, 502-855-5314, www.patentinsurance.com.

About IPISC

IPISC is the industry leader and expert in Intellectual Property Insurance.  Because we have been in the business of managing risk and protecting the value of client's IP assets for over 23 years, we have developed products that use advanced strategies to become market leaders in the dynamic field of IP insurance.  We are committed to providing you top-notch underwriting, insurance products and services.

 


'/>"/>
SOURCE Intellectual Property Insurance Services Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Evaluates Psychotropic Prescribing For Persons with Intellectual Disabilities, Other Psychiatric Disorders
2. Free Download -- Two impressive case studies on Pharmaceutical Intellectual Property
3. 2013 Pharmaceutical Intellectual Property Forum is Coming in November
4. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
5. Intellectual Property Insurance for the Medical-Related Products Industry
6. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
7. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
8. Call for Submissions: ICAP Patent Brokerage Announces Expansion of Life Sciences Practice and Increased Buyer Interest in Related Intellectual Property
9. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
10. iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform
11. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, e lançamento de produto ... gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
(Date:12/8/2016)... 2016 Information products and services provider ... Scopus , the world,s largest abstract and citation database of ... for journals from over 5,000 publishers. The new set of metrics ... to and when to adjust a journal,s editorial strategy. ... , , ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... Charlotte, NC (PRWEB) , ... December 08, 2016 ... ... repeal Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass ... A story movement gives people ongoing opportunities to share their unfortunate experiences; such ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... serve communities in and around the greater Phoenix metropolitan region, is announcing a ... , The mission of the Homeless Youth Connection is to promote community awareness ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a simple, ... and tightening the skin of the face to create more youthful features. While ... very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure that ...
Breaking Medicine News(10 mins):